Daniel Thorek

26PUBLICATIONS
104CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInstruments and techniquesMedical infection agents (incl. prions)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 26, 2026
Reply to Çınar, A. The Potential Role of Organ-to-Liver Ratios in Immune-Related FDG PET Imaging. Comment on "Panikar et al. Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis. Int. J. Mol. Sci. 2026, 27, 5129".

|Sep 22, 2026
Key regulatory elements of the TGFβ-LRRC15 axis predict disease progression and immunotherapy resistance across cancer types.

|Jul 04, 2026
Stable Chelation of Zr-89 and Ac-225 with Dual Size-Selective Macrocyclic py2-macrodipa for 225Ac/89Zr Paired Theranostics.

|Jun 12, 2026
Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.

|May 22, 2026
A Siderophore-Antibiotic Heterodimer Imaging Agent Enables In Vivo PET Imaging of S. aureus Infections.

|Mar 13, 2026
Zwitterionic Modification of PSMA Ligands Reduces Off-Target Binding and Tissue Retention.

Lennart F V Spickschen, Roland Thünauer, Aleksander J Swierzewski

Pageof 5

Frequent Collaborators

4 joint publications

Richard Wahl

4 joint publications

Claire M Storey

3 joint publications

W Nathaniel Brennen

3 joint publications

Ken Herrmann